Effects of an ARB on Endothelial Progenitor Cell Function and Cardiovascular Oxidation in Hypertension
Author(s) -
Liang Yu,
Noboru Fukuda,
EnHui Yao,
Takeshi Matsumoto,
Norihiro Kobayashi,
Ryo Suzuki,
Y. Tahira,
Takahiro Ueno,
Ken Matsumoto
Publication year - 2007
Publication title -
american journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.009
H-Index - 136
eISSN - 1941-7225
pISSN - 0895-7061
DOI - 10.1038/ajh.2007.5
Subject(s) - candesartan , medicine , tbars , endocrinology , oxidative stress , angiotensin ii , nadph oxidase , endothelial progenitor cell , progenitor cell , nicotinamide adenine dinucleotide phosphate , pharmacology , endothelial dysfunction , blood pressure , oxidase test , lipid peroxidation , biology , biochemistry , stem cell , enzyme , genetics
Angiotensin II (Ang II) receptor blocker (ARB) has been reported to have protective effects on the cardiovascular system independent of blood pressure reduction. Endothelial progenitor cells (EPCs) play a significant role in neovascularization of ischemic tissue. The average lifespan of EPCs was recently reported to be shortened by oxidative stress and regulated by anti-oxidative mechanisms. It has been reported that EPCs are present in peripheral blood and have the ability to repair cardiovascular damage. We investigated the effects of an ARB, candesartan, on EPC function and cardiovascular oxidation in salt-loaded, stroke-prone, spontaneously hypertensive rats (SHR-SP) in vivo.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom